| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb0eaf7da6b4e6867fd9a1f651d9f91d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26 |
| filingDate |
2004-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1385edb3510970e94c7fcbc421785e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_818ec9193fde0e69c38532d10ce225cc |
| publicationDate |
2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7723042-B2 |
| titleOfInvention |
Methods for differentiating and monitoring parathyroid and bone status related diseases |
| abstract |
The present invention relates to novel methods and devices for differentiating in a patient parathyroid diseases, such as hyperparathyroidism and related bone diseases, from normal or non-disease states. One detects whole or non-fragmented (1 to 84) parathyroid hormone in a biological sample and also a large non-whole parathyroid hormone peptide fragment that can function as a parathyroid hormone antagonist. By either comparing values or using independently the value of either the large non-whole parathyroid hormone peptide fragment, the whole parathyroid hormone, or the combination of these values one is able to differentiate parathyroid and bone related disease states, as well as differentiate such states from normal states. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219598-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7892749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007287668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004185536-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008069828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010186100-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470543-B2 |
| priorityDate |
1999-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |